Remove 2021 Remove Life Science Remove Medical Technology Remove Telemedicine
article thumbnail

Health Is Everywhere at #CES2021 – CTA’s CES 2021 Tech Trends to Watch

Health Populi

will reach $845 million based on the forecast of the Consumer Technology Association, convening the annual 2021 CES this week in a virtual format. CTA unveiled the 2021 key trends we’ll see presented this week through the online exhibition hall and in educational sessions on the CES.Tech platform. For the U.S.,

article thumbnail

IoT and The Rise of the Machines in Healthcare

Health Populi

During the first year of the COVID-19 pandemic, the health care sector was profoundly affected by cyber-attacks on connected devices, we learn in the report, Rise of the Machines 2021: State of Connected Devices – IT, IoT, IoMT and OT from Ordr.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

Health Populi

In October 2021, the Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, would give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry.

article thumbnail

Our Homes Are Health Delivery Platforms – The New Home Health/Care at CES 2021

Health Populi

CES 2021 featured some obvious quick-pivoting products that had the pandemic written all over them, with sessions invariably speaking to the way the public health crisis impacted companies and strategic plans. Joining Peloton in connected fitness at CES 2021 was NordicTrack, which recently announced its purchase of Precor.

article thumbnail

The Coronavirus Pandemic Turbocharged Digital Health Investment in 2020

Health Populi

Rock Health expects telemedicine encounters to be at a greater volume in 2021 versus 2019, with some “settling” to a less hyped level than seen at the height of the pandemic. Four groups made up most of this investment cohort: health care providers, technology companies, biopharma/life science, and health care payers.